Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-04 Sale | 2026-03-06 4:33 pm | VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer | 18,341 | $36.14 | $662,869 | 131,196 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:32 pm | VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer | 45,523 | $35.97 | $1,637,594 | 357,554 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:32 pm | VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA | 5,260 | $35.19 | $185,083 | 107,580 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:32 pm | VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel | 6,658 | $35.55 | $236,725 | 94,706 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 4:16 pm | VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer | 13,425 | $36.16 | $485,429 | 117,346 (Direct) | View |
| 2025-12-16 Sale | 2025-12-17 4:35 pm | VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel | 10,739 | $43.13 | $463,204 | 67,760 (Direct) | View |
| 2025-12-05 Sale | 2025-12-08 4:34 pm | VERACYTE INC. | VCYT | EASTHAM KARIN Director | 20,000 | $45.45 | $908,923 | 13,554 (Direct) | View |
| 2025-12-04 Sale | 2025-12-04 7:44 pm | VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel | 1,422 | $47.3 | $67,261 | 78,499 (Direct) | View |
| 2025-12-04 Sale | 2025-12-04 7:44 pm | VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer | 13,278 | $46.84 | $621,955 | 109,496 (Direct) | View |
| 2025-12-04 Sale | 2025-12-04 7:44 pm | VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer | 7,668 | $47.09 | $361,076 | 318,603 (Direct) | View |
| 2025-12-04 Sale | 2025-12-04 7:43 pm | VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA | 1,278 | $47.51 | $60,718 | 82,113 (Direct) | View |
| 2025-11-25 Sale | 2025-11-26 4:27 pm | VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA | 2,808 | $50 | $140,400 | 86,291 (Direct) | View |
| 2025-11-25 Sale | 2025-11-26 4:27 pm | VERACYTE INC. | VCYT | JONES EVAN Director | 1,106 | $50.25 | $55,576 | 29,362 (Direct) | View |
| 2025-11-20 Sale | 2025-11-21 4:19 pm | VERACYTE INC. | VCYT | Holstein Jens Director | 10,000 | $42.36 | $423,563 | 27,199 (Direct) | View |
| 2025-11-07 Sale | 2025-11-12 4:25 pm | VERACYTE INC. | VCYT | Wygant Jonathan VP, Chief Accounting Officer | 10,920 | $41.2 | $449,907 | 38,745 (Direct) | View |
| 2025-11-05 Sale | 2025-11-07 4:10 pm | VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel | 6,466 | $40 | $258,640 | 82,973 (Direct) | View |
| 2025-11-05 Sale | 2025-11-07 4:10 pm | VERACYTE INC. | VCYT | JONES EVAN Director | 43,196 | $45.06 | $1,946,288 | 30,468 (Direct) | View |
| 2025-11-05 Sale | 2025-11-07 4:10 pm | VERACYTE INC. | VCYT | EASTHAM KARIN Director | 9,674 | $40.02 | $387,191 | 13,554 (Direct) | View |
| 2025-11-05 Sale | 2025-11-07 4:10 pm | VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer | 7,000 | $41 | $287,000 | 126,158 (Direct) | View |
| 2025-10-06 Sale | 2025-10-07 4:27 pm | VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer | 8,349 | $36.02 | $300,709 | 92,441 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 4:16 pm | VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA | 2,539 | $35 | $88,865 | 89,099 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-06 Option Award | 2026-03-10 5:10 pm | N/A N/A | VERACYTE INC. | VCYT | Wygant Jonathan VP, Chief Accounting Officer | 10,525 | $0 | 45,434 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 5:10 pm | N/A N/A | VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel | 59,206 | $0 | 153,912 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 5:10 pm | N/A N/A | VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer | 36,181 | $0 | 153,527 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 5:10 pm | N/A N/A | VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA | 42,759 | $0 | 150,339 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 5:10 pm | N/A N/A | VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer | 92,099 | $0 | 449,653 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 5:09 pm | N/A N/A | VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer | 49,338 | $0 | 180,534 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-04 4:17 pm | N/A N/A | VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel | 6,902 | $36.01 | 101,364 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-04 4:17 pm | N/A N/A | VERACYTE INC. | VCYT | Wygant Jonathan VP, Chief Accounting Officer | 3,006 | $36.01 | 34,909 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-04 4:16 pm | N/A N/A | VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer | 7,234 | $36.01 | 149,537 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-04 4:16 pm | N/A N/A | VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA | 7,517 | $36.01 | 112,840 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-04 4:16 pm | N/A N/A | VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer | 6,035 | $36.01 | 117,346 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-04 4:16 pm | N/A N/A | VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer | 19,455 | $36.01 | 403,077 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:53 pm | N/A N/A | VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA | 47,149 | $0 | 120,357 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-03-02 4:53 pm | N/A N/A | VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA | 8,905 | $38.75 | 120,357 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:53 pm | N/A N/A | VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer | 139,074 | $0 | 422,532 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-03-02 4:53 pm | N/A N/A | VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer | 35,841 | $38.75 | 422,532 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:53 pm | N/A N/A | VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer | 59,324 | $0 | 156,771 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-03-02 4:53 pm | N/A N/A | VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer | 12,049 | $38.75 | 156,771 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:52 pm | N/A N/A | VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer | 71,806 | $0 | 136,806 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-03-02 4:52 pm | N/A N/A | VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer | 24,486 | $38.75 | 136,806 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:52 pm | N/A N/A | VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel | 50,999 | $0 | 108,266 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-03-02 4:52 pm | N/A N/A | VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel | 10,867 | $38.75 | 108,266 (Direct) | View |
| 2025-12-05 Exercise | 2025-12-08 4:34 pm | N/A N/A | VERACYTE INC. | VCYT | EASTHAM KARIN Director | 10,000 | $7.6 | 13,554 (Direct) | View |
| 2025-12-05 Exercise | 2025-12-08 4:34 pm | N/A 2027-06-07 | VERACYTE INC. | VCYT | EASTHAM KARIN Director | 20,000 | $0 | 13,554 (Direct) | View |
| 2025-12-05 Exercise | 2025-12-08 4:34 pm | N/A N/A | VERACYTE INC. | VCYT | EASTHAM KARIN Director | 10,000 | $7.94 | 13,554 (Direct) | View |
| 2025-12-02 Tax Withholding | 2025-12-04 7:44 pm | N/A N/A | VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer | 2,955 | $46.16 | 89,486 (Direct) | View |
| 2025-12-02 Tax Withholding | 2025-12-04 7:44 pm | N/A N/A | VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel | 3,052 | $46.16 | 78,499 (Direct) | View |
| 2025-12-02 Tax Withholding | 2025-12-04 7:44 pm | N/A N/A | VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer | 3,384 | $46.16 | 109,496 (Direct) | View |
| 2025-12-02 Tax Withholding | 2025-12-04 7:44 pm | N/A N/A | VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer | 7,914 | $46.16 | 318,603 (Direct) | View |
| 2025-12-02 Tax Withholding | 2025-12-04 7:43 pm | N/A N/A | VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA | 2,900 | $46.16 | 82,113 (Direct) | View |
| 2025-12-02 Tax Withholding | 2025-12-04 7:43 pm | N/A N/A | VERACYTE INC. | VCYT | Wygant Jonathan VP, Chief Accounting Officer | 1,325 | $46.16 | 37,420 (Direct) | View |
| 2025-11-05 Exercise | 2025-11-07 4:10 pm | N/A N/A | VERACYTE INC. | VCYT | JONES EVAN Director | 10,000 | $7.6 | 30,468 (Direct) | View |
| 2025-11-05 Exercise | 2025-11-07 4:10 pm | N/A 2026-06-20 | VERACYTE INC. | VCYT | JONES EVAN Director | 30,000 | $0 | 30,468 (Direct) | View |
| 2025-11-05 Exercise | 2025-11-07 4:10 pm | N/A N/A | VERACYTE INC. | VCYT | JONES EVAN Director | 10,000 | $5.28 | 30,468 (Direct) | View |
| 2025-11-05 Exercise | 2025-11-07 4:10 pm | N/A N/A | VERACYTE INC. | VCYT | JONES EVAN Director | 10,000 | $7.94 | 30,468 (Direct) | View |
| 2025-10-28 Option Award | 2025-10-30 4:39 pm | N/A N/A | VERACYTE INC. | VCYT | Wygant Jonathan VP, Chief Accounting Officer | 2,886 | $0 | 49,665 (Direct) | View |